ArticleDrugs in context2020

Efficacy and safety of a GABAergic drug (Gamalate® B6): effects on behavior and cognition in young adults with borderline-to-mild intellectual developmental disabilities and ADHD.

Ramón Novell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.